This Article Full Text Full Text (PDF) All Versions of this Article: 29/5/499    most recent Author Manuscript (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wang, M.-H. Articles by Baskin, L. S. Search for Related Content PubMed PubMed Citation Articles by Wang, M.-H. Articles by Baskin, L. S.

Review

Endocrine Disruptors, Genital Development, and Hypospadias

From the UCSF Children's Hospital, Department of Urology, University of California, San Francisco, California.

Correspondence to: Laurence S. Baskin, MD, Chief, Pediatric Urology, Professor Urology and Pediatrics, UCSF Children's Hospital, University of California, San Francisco, 400 Parnassus Avenue A640, San Francisco, CA 94143 (e-mail: lbaskin{at}urology.ucsf.edu).

Abstract

Hypospadias is one of the most common congenital anomalies in the United States, occurring in approximately 1 in 125 live male births. Embryological studies have demonstrated that, depending on where the urethral development arrests, the meatal opening can be anywhere along the shaft of the penis or, in more severe forms, within the scrotum or in the perineum. Currently, the only available treatment is surgery. If left uncorrected, especially in its severe form, there is risk of infertility and psychological effects, such as avoidance of intimate relationships. The cause of hypospadias is largely unknown; however, current epidemiology and laboratory studies have shed new light into the etiology of hypospadias. With recent advancements in molecular biology and microarray technology, it appears that hypospadias is potentially related to disrupted gene expression. Specifically, some of the environmental chemicals are acting as antiandrogens and interfere directly with the action of testosterone-related gene expression. In this paper, we briefly review the normal development of male external genitalia and the prevalence and environmental risk factors related to hypospadias. In addition, we discuss some of the recent laboratory findings that contribute to our current understanding of this disease.

This article has been cited by other articles:

				E. Rodriguez Jr, D. A. Weiss, J. H. Yang, J. Menshenina, M. Ferretti, T. J. Cunha, D. Barcellos, L. Y. Chan, G. Risbridger, G. R. Cunha, et al. New Insights on the Morphology of Adult Mouse Penis Biol Reprod, December 1, 2011; 85(6): 1216 - 1221. [Abstract] [Full Text] [PDF]

				I. A. Hughes 13.9.3 Normal and abnormal sexual differentiation OTM, November 30, 2011; 5(1): med-9780199204854-chapter - med-9780199204854-chapter. [Abstract] [Full Text]

				G. L. Warne and J. K. Hewitt 7.1.3 Sex determination and differentiation Oxford Textbook of Endocrinology and Diabetes, July 1, 2011; 2(1): med-9780199235292-chapter - med-9780199235292-chapter. [Abstract] [Full Text]

				N. Iszatt, M. J. Nieuwenhuijsen, P. Nelson, P. Elliott, and M. B. Toledano Water Consumption and Use, Trihalomethane Exposure, and the Risk of Hypospadias Pediatrics, February 1, 2011; 127(2): e389 - e397. [Abstract] [Full Text] [PDF]

				H. Chen, W. Yong, T. D. Hinds Jr, Z. Yang, Y. Zhou, E. R. Sanchez, and W. Shou Fkbp52 Regulates Androgen Receptor Transactivation Activity and Male Urethra Morphogenesis J. Biol. Chem., September 3, 2010; 285(36): 27776 - 27784. [Abstract] [Full Text] [PDF]

				H. M. Scott, J. I. Mason, and R. M. Sharpe Steroidogenesis in the Fetal Testis and Its Susceptibility to Disruption by Exogenous Compounds Endocr. Rev., December 1, 2009; 30(7): 883 - 925. [Abstract] [Full Text] [PDF]

				B. Kohler, L. Lin, I. Mazen, C. Cetindag, H. Biebermann, I. Akkurt, R. Rossi, O. Hiort, A. Gruters, and J. C Achermann The spectrum of phenotypes associated with mutations in steroidogenic factor 1 (SF-1, NR5A1, Ad4BP) includes severe penoscrotal hypospadias in 46,XY males without adrenal insufficiency Eur. J. Endocrinol., August 1, 2009; 161(2): 237 - 242. [Abstract] [Full Text] [PDF]